Search Results - "Carpelan‐Holmström, M."

  • Showing 1 - 20 results of 20
Refine Results
  1. 1

    Does anyone survive pancreatic ductal adenocarcinoma? A nationwide study re-evaluating the data of the Finnish Cancer Registry by Carpelan-Holmström, M, Nordling, S, Pukkala, E, Sankila, R, Lüttges, J, Klöppel, G, Haglund, C

    Published in Gut (01-03-2005)
    “…Background: Worldwide survival data for ductal adenocarcinoma of the pancreas are the lowest among the 60 most frequent types of organ cancers. Hence published…”
    Get full text
    Journal Article
  2. 2

    Clinical management of 52 consecutive retro‐rectal tumours treated at a tertiary referral centre by CarpelanHolmström, M., Koskenvuo, L., Haapamäki, C., Renkonen‐Sinisalo, L., Lepistö, A.

    Published in Colorectal disease (01-10-2020)
    “…Aim The aim of this single‐institution study was to analyse the diagnostic methods, preoperative work‐up and outcomes of 52 retro‐rectal tumours. Method All…”
    Get full text
    Journal Article
  3. 3

    Oncological outcomes before and after the extralevator abdominoperineal excision era in rectal cancer patients treated with abdominoperineal excision in a single centre, high volume unit by Lehtonen, T., Räsänen, M., CarpelanHolmström, M., Lepistö, A.

    Published in Colorectal disease (01-02-2019)
    “…Aim The extralevator abdominoperineal excision (ELAPE) has been expected to reduce the risk of positive circumferential resection margins (CRMs) and local…”
    Get full text
    Journal Article
  4. 4

    The Results of Pancreatic Resections and Long-Term Survival for Pancreatic Ductal Adenocarcinoma: A Single-Institution Experience by Seppänen, H., Juuti, A., Mustonen, H., Haapamäki, C., Nordling, S., Carpelan-Holmström, M., Sirén, J., Luettges, J., Haglund, C., Kiviluoto, T.

    Published in Scandinavian journal of surgery (01-03-2017)
    “…Objectives: Since the early 1990s, low long-term survival rates following pancreatic surgery for pancreatic ductal adenocarcinoma have challenged us to improve…”
    Get full text
    Journal Article
  5. 5

    Pre-operative serum levels of CA 242 and CEA predict outcome in colorectal cancer by Carpelan-holmström, M., Haglund, C., Lundin, J., Järvinen, H., Roberts, P.

    Published in European journal of cancer (1990) (01-06-1996)
    “…The prognostic value of the preoperative serum levels of CA 242 and CEA in patients with colorectal cancer was investigated. The serum concentrations of CA 242…”
    Get full text
    Journal Article
  6. 6

    Laparoscopic ventral rectopexy in male patients with external rectal prolapse is associated with a high reoperation rate by Rautio, T., Mäkelä-Kaikkonen, J., Vaarala, M., Kairaluoma, M., Kössi, J., Carpelan-Holmström, M., Salmenkylä, S., Ohtonen, P., Mäkelä, J.

    Published in Techniques in coloproctology (01-10-2016)
    “…Background Laparoscopic ventral rectopexy has been used to treat male patients with external rectal prolapse, but evidence to support this approach is scarce…”
    Get full text
    Journal Article
  7. 7

    Smoking Increases the Incidence of Complicated Diverticular Disease of the Sigmoid Colon by Turunen, P., Wikström, H., Carpelan-Holmström, M., Kairaluoma, P., Kruuna, O., Scheinin, T.

    Published in Scandinavian journal of surgery (01-01-2010)
    “…Backround and Aims: The aim of this study was to establish whether smoking is associated with complicated diverticular disease and adverse outcomes of…”
    Get full text
    Journal Article
  8. 8

    Late mesh migration through the stomach wall after laparoscopic refundoplication using a dual-sided PTFE/ePTFE mesh by Carpelan-Holmström, M., Kruuna, O., Salo, J., Kylänpää, L., Scheinin, T.

    “…We report a rare complication after laparoscopic fundoplication using a dual-sided PTFE/ePTFE (Bard® Crurasoft™) mesh fixation. A 53-year-old man was…”
    Get full text
    Journal Article
  9. 9

    Laparoscopic rectal prolapse surgery combined with short hospital stay is safe in elderly and debilitated patients by CARPELAN-HOLMSTRÖM, M, KRUUNA, O, SCHEININ, T

    Published in Surgical endoscopy (01-09-2006)
    “…We report the results of patients treated from January 2000 to June 2004 for full-thickness rectal prolapse with trans-abdominal surgery in Helsinki…”
    Get full text
    Journal Article
  10. 10

    Improved long term survival after extended pancreatic cancer operations: A single-institution experience by Seppänen, H, Juuti, A, Mustonen, H, Haapamäki, C, Nordling, S, Carpelan-Holmström, M, Sirén, J, Haglund, C, Kiviluoto, T

    “…Extended resection included right side omentectomy, excision of the right cranial peritoneal leaf revealing caval vein and the renal veins, excision of the…”
    Get full text
    Journal Article
  11. 11

    Sialyl Tn is a frequently expressed antigen in colorectal cancer: No correlation with patient prognosis by Lundin, M, Nordling, S, Roberts, P J, Lundin, J, Carpelan-Holmström, M, von Boguslawsky, K, Haglund, C

    Published in Oncology (01-07-1999)
    “…Immunohistochemical expression of sialyl Tn antigen (STn), previously claimed to be a prognostic factor in colorectal cancer, was evaluated in 239 patients…”
    Get more information
    Journal Article
  12. 12
  13. 13

    Preoperative serum levels of CEA and CA 242 in colorectal cancer by CARPELAN-HOLMSTRÖM, M, HAGLUND, C, KUUSELA, P, JÄRVINEN, H, ROBERTS, P. J

    Published in British journal of cancer (01-04-1995)
    “…Preoperative serum levels of CEA and CA 242 were determined in 260 patients with colorectal cancer and in 92 patients with benign colorectal diseases. The…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Differences in serum tumor markers between colon and rectal cancer. Comparison of CA 242 and carcinoembryonic antigen by Carpelan-Holmström, M A, Haglund, C H, Roberts, P J

    Published in Diseases of the colon & rectum (01-07-1996)
    “…We investigated whether there are differences in serum levels of CA 242 and carcinoembryonic antigen (CEA) between patients with colon and rectal cancer…”
    Get more information
    Journal Article
  16. 16

    Serum CA 242 and CEA detect different patients with recurrent colorectal cancer by Carpelan-Holmström, M A, Haglund, C H, Järvinen, H J, Roberts, P J

    Published in Anticancer research (01-03-1996)
    “…The aim of this study was to investigate the clinical value of CA 242 and CEA in the follow-up of patients with colorectal cancer. Serial serum samples were…”
    Get more information
    Journal Article
  17. 17

    A comparison of serum and tissue hCG beta as prognostic markers in colorectal cancer by Lundin, M, Nordling, S, Carpelan-Holmstrom, M, Louhimo, J, Alfthan, H, Stenman, U H, Haglund, C

    Published in Anticancer research (01-11-2000)
    “…Production of the glycoprotein hormone hCG beta has been associated with aggressive behavior in nontrophoblastic tumors. In this study the prognostic value of…”
    Get more information
    Journal Article
  18. 18

    CEA, CA 19-9 and CA 72-4 improve the diagnostic accuracy in gastrointestinal cancers by Carpelan-Holmström, M, Louhimo, J, Stenman, U H, Alfthan, H, Haglund, C

    Published in Anticancer research (01-07-2002)
    “…CEA, CA 19-9, CA 242 and CA 72-4 are commonly used tumour markers for gastrointestinal malignancies. The advantage of the concomitant use of these markers is…”
    Get more information
    Journal Article
  19. 19

    Serum HCGβ, CA 72‐4 and CEA are independent prognostic factors in colorectal cancer by Louhimo, Johanna, Carpelan‐Holmström, Monika, Alfthan, Henrik, Stenman, Ulf‐Håkan, Järvinen, Heikki J., Haglund, Caj

    Published in International journal of cancer (20-10-2002)
    “…In colorectal cancer, stage is considered to be the strongest prognostic factor, but also serum tumour markers have been reported to be of prognostic value…”
    Get full text
    Journal Article
  20. 20

    Estimating the probability of cancer with several tumor markers in patients with colorectal disease by Carpelan-Holmström, Monika, Louhimo, Johanna, Stenman, Ulf-Håkan, Alfthan, Henrik, Järvinen, Heikki, Haglund, Caj

    Published in Oncology (01-01-2004)
    “…The purpose of this study was to evaluate and compare serum tumor markers, carcinoembryonic antigen (CEA), CA 19-9, CA 242, CA 72-4 and hCGbeta, and their…”
    Get more information
    Journal Article